The Hill reports:
The final testing stage for a potential coronavirus vaccine developed by Moderna is set to begin in July, The Wall Street Journal reported Wednesday.
John Mascola, the director of the vaccine research center at the National Institute of Allergy and Infectious Diseases, told the Journal that the trials will involve about 30,000 people at more than 50 sites, which will mostly be within the U.S.
The third phase of testing for potential vaccines developed Oxford University and AstraZeneca’s will begin in August while the last trials for one developed by Johnson & Johnson will start in September, Mascola told the newspaper.
The original report is behind a paywall. Dozens of other potential vaccines are in varying stages in testing.